Department of Pharmaceutical Sciences, University of Toronto , Toronto, Ontario M5S 3M2, Canada.
Institute of Biomaterials and Biomedical Engineering, University of Toronto , Toronto, Ontario M5S 3G4, Canada.
Chem Rev. 2016 Aug 24;116(16):9001-90. doi: 10.1021/acs.chemrev.6b00220. Epub 2016 Jul 18.
Rapid progress in identifying biomarkers that are hallmarks of disease has increased demand for high-performance detection technologies. Implementation of electrochemical methods in clinical analysis may provide an effective answer to the growing need for rapid, specific, inexpensive, and fully automated means of biomarker analysis. This Review summarizes advances from the past 5 years in the development of electrochemical sensors for clinically relevant biomolecules, including small molecules, nucleic acids, and proteins. Various sensing strategies are assessed according to their potential for reaching relevant limits of sensitivity, specificity, and degrees of multiplexing. Furthermore, we address the remaining challenges and opportunities to integrate electrochemical sensing platforms into point-of-care solutions.
在识别疾病标志物方面的快速进展增加了对高性能检测技术的需求。电化学方法在临床分析中的应用可能为快速、特异、廉价和完全自动化的生物标志物分析手段提供有效答案。本综述总结了过去 5 年在用于临床相关生物分子(包括小分子、核酸和蛋白质)的电化学传感器开发方面的进展。根据其达到相关灵敏度、特异性和多重检测程度的潜力,对各种传感策略进行了评估。此外,我们还讨论了将电化学传感平台集成到即时检测解决方案中所面临的挑战和机遇。